T205I-新冠突变重组蛋白

SARS-CoV-2 (2019-nCoV) Nucleocapsid (T205I) Protein (His Tag): 产品信息
纯度> 95 % as determined by SDS-PAGE.
内毒素Please contact us for more information.
生物活性Testing in progress
蛋白构建A DNA sequence encoding the SARS-CoV-2 (2019-nCoV) Nucleocapsid (YP_009724397.2, with mutation T205I) (Met1-Ala419) was expressed with a polyhistidine tag at the N-terminus. The mutation were identified in the SARS-CoV-2 variant (known as 20C/501Y.V2 or B.1.351 lineage) which emerged in South Africa.
表达宿主E. coli
种属SARS-CoV-2
预测 N 端Met
分子量The recombinant SARS-CoV-2 (2019-nCoV) Nucleocapsid consists of 426 amino acids and predicts a molecular mass of 46.6 kDa.
缓冲液Lyophilized from sterile 50 mM PB, 500 mM NaCl, pH 7.0.
Please contact us for any concerns or special requirements.
Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the hard copy of CoA.
运输方式In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.
Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
稳定性 & 储存条件Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃
Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
复溶A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.